Noninvasive strategies for breast cancer early detection. (Q38885953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

Noninvasive strategies for breast cancer early detection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Pablo Martinez-Lozano Sinues

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

English

0 references

publication date

5 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

1395-1411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Clinical management of breast cancer heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Challenges to effective cancer control in China, India, and Russia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Prioritizing targets for precision cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

21 January 2018

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Translational implications of tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Molecular evolution of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Future directions in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Role of inflammatory infiltrates in triple negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Assessment, origin, and implementation of breath volatile cancer markers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Onco-proteogenomics: cancer proteomics joins forces with genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Systems biology: Metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

The evidence base for breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Pan-Canadian study of mammography screening and mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Breast-cancer screening--viewpoint of the IARC Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

The randomized trials of breast cancer screening: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Breast cancer screening in women: An integrative literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Dynamic contrast-enhanced breast MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Utilisation of MR spectroscopy and diffusion weighted imaging in predicting and monitoring of breast cancer response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

The Clinical Relevance of Long Non-Coding RNAs in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Human body fluid proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Proteomics for breast cancer urine biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Peptidomics of urine and other biofluids for cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Human saliva proteome analysis and disease biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Biomarkers for risk assessment and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Gene expression profiling of peripheral blood cells for early detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Diagnosis and treatment of cancer using genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

High-throughput sequencing technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Methylated circulating tumor DNA in blood: power in cancer prognosis and response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Circulating miRNAs as new blood-based biomarkers for solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Use of autoantibodies to detect the onset of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Electrochemical immunosensors in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Multiplex serum cytokine immunoassay using nanoplasmonic biosensor microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Cytokines and their relationship to the symptoms and outcome of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Advances in mass spectrometry-based clinical biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Glycosylation in cancer: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Breast cancer classification by proteomic technologies: current state of knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Detection of Elevated Plasma Levels of Epidermal Growth Factor Receptor Before Breast Cancer Diagnosis among Hormone Therapy Users

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Peptidomics for cancer diagnosis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Metabolomics Biomarkers for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Detection of lung cancer with volatile markers in the breath

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Prediction of breast cancer using volatile biomarkers in the breath.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Volatile markers of breast cancer in the breath

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Thermal Degradation of Small Molecules: A Global Metabolomic Investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Volatile biomarkers in the breath of women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Noninvasive detection of lung cancer by analysis of exhaled breath

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Proton-Transfer Reaction Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Proton-transfer-reaction mass spectrometry (PTR–MS): on-line monitoring of volatile organic compounds at pptv levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Fingerprinting breast cancer vs. normal mammary cells by mass spectrometric analysis of volatiles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Data interpretation in breath biomarker research: pitfalls and directions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Si:WO(3) Sensors for highly selective detection of acetone for easy diagnosis of diabetes by breath analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Analysis of the exhalome: a diagnostic tool of the future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

Why Do Purely Intraductal Cancers Enhance on Breast MR Images?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON-2015-0071

21 January 2018

Identifiers

DOI

10.2217/FON-2015-0071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27044539%20AND%20SRC:MED&resulttype=core&format=json